Detalhe da pesquisa
1.
Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial Carcinoma.
Oncology
; 98(3): 146-153, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31794969
2.
Tuning the emission color of organic semiconductor films with cholesteric liquid crystals.
Opt Express
; 25(10): 11211-11216, 2017 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28788802
3.
Comment on: Environmental sustainability in robotic and laparoscopic surgery: systematic review.
Br J Surg
; 110(1): 120, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327424
4.
Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
Br J Surg
; 108(5): e211, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709103
5.
Prognostic model to predict survival in patients with metastatic upper tract urothelial carcinoma treated with cisplatin-based chemotherapy.
Int J Urol
; 23(5): 385-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26992082
6.
Improvement of clinical wound microcirculation diagnosis using an object tracking-based laser speckle contrast imaging system.
APL Bioeng
; 8(1): 016105, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38292062
7.
Assessing the effectiveness of targeted agents in adjuvant therapy for patients with metastatic colorectal cancer undergoing surgical resection: a retrospective cohort study.
Ther Adv Med Oncol
; 16: 17588359241246427, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38655393
8.
A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Retrospective Multicenter Analysis.
Target Oncol
; 19(1): 71-79, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041732
9.
Programmed Death Ligand-1 and Tumor Burden Score Dictate Treatment Responses in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 16(9)2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730699
10.
Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08).
Target Oncol
; 19(1): 51-58, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38285067
11.
Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database.
Head Neck
; 46(5): 1063-1073, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385970
12.
Comparative Effectiveness of Cetuximab Versus Panitumumab in Patients With Metastatic Colorectal Cancer: A Nationwide Database Study.
Anticancer Res
; 43(11): 5127-5138, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37909992
13.
Mortality of patients with metastatic colorectal cancer who received elective or emergent operation after exposure to bevacizumab: A nationwide database study.
Eur J Surg Oncol
; 49(2): 445-451, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208981
14.
Prognostic impact of cortactin in patients with hypopharyngeal cancer and its role for tegafur-uracil maintenance after adjuvant chemoradiotherapy.
Am J Cancer Res
; 13(11): 5504-5512, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058839
15.
Medium-term surgical outcomes and health-related quality of life after laparoscopic vs open colorectal cancer resection: SF-36 health survey questionnaire.
World J Gastrointest Endosc
; 15(3): 163-176, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034974
16.
Inhibition of lncRNA RPPH1 activity decreases tumor proliferation and metastasis through down-regulation of inflammation-related oncogenes.
Am J Transl Res
; 15(12): 6701-6717, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38186977
17.
Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study.
Nutrients
; 15(13)2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37447297
18.
Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registry.
Am J Cancer Res
; 13(12): 6333-6345, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187069
19.
Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection.
Cancers (Basel)
; 14(9)2022 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565247
20.
Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice Versa.
Cancers (Basel)
; 14(10)2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35625956